Iams Wealth Management’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-38,240
Closed -$912K 239
2023
Q2
$912K Buy
+38,240
New +$874K 0.33% 84

Iams Wealth Management's SENT Position: Q4 2023 in Review

Iams Wealth Management sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q4 2023, closing a stake of 19,120 shares — an estimated $425K sold.

Iams Wealth Management first reported a position in SENT in Q4 2022 and held it in 3 quarters. The position peaked at $455K in Q1 2023. 0 funds tracked by Wall St. Rank hold SENT as of Q4 2023.

  • Iams Wealth Management reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q4 2023 after selling out during the quarter.
  • Iams Wealth Management sold 19,120 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q4 2023, an estimated $425K.
  • Iams Wealth Management first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q4 2022 and held it in 3 quarters.
  • Iams Wealth Management's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $455K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q4 2023.

Based on Iams Wealth Management's 13F filing for Q4 2023, filed 7 Feb 2024.